We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-8.89%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.51B
AUM Growth
-$307M
Cap. Flow
+$14.9M
Cap. Flow %
0.6%
Top 10 Hldgs %
23.56%
Holding
327
New
15
Increased
111
Reduced
164
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 29.36%
2 Healthcare 23.72%
3 Industrials 14.58%
4 Consumer Discretionary 12.89%
5 Communication Services 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUPN icon
26
Supernus Pharmaceuticals
SUPN
$2.77B
$27.6M 1.1%
854,949
-1,906
-0.2% -$58.4K
MMS icon
27
Maximus
MMS
$3.1B
$27.1M 1.08%
361,661
-6,469
-2% -$495K
SSTK icon
28
Shutterstock
SSTK
$219M
$26.9M 1.07%
288,481
-2,119
-0.7% -$197K
OZK icon
29
Bank OZK
OZK
$5.61B
$25.8M 1.03%
604,736
-12,478
-2% -$582K
BBBY
30
Bed Bath & Beyond
BBBY
$442M
$24.5M 0.98%
612,834
+127,099
+26% +$5.65M
XPO icon
31
XPO
XPO
$23.7B
$24.3M 0.97%
560,821
+57,488
+11% +$2.4M
ON icon
32
ON Semiconductor
ON
$31.6B
$23.9M 0.95%
381,259
-42,474
-10% -$2.59M
AGM icon
33
Federal Agricultural Mortgage
AGM
$2.56B
$23.8M 0.95%
219,346
+2,039
+0.9% +$249K
IAA
34
DELISTED
IAA, Inc. Common Stock
IAA
$23.1M 0.92%
603,195
-10,140
-2% -$417K
CEVA icon
35
CEVA Inc
CEVA
$1.08B
$22.9M 0.91%
563,538
-981
-0.2% -$38.1K
QLYS icon
36
Qualys
QLYS
$6.35B
$21.7M 0.87%
152,724
-2,766
-2% -$353K
RVNC
37
DELISTED
Revance Therapeutics, Inc.
RVNC
$21.7M 0.86%
1,112,325
-1,620
-0.1% -$24.6K
APPS icon
38
Digital Turbine
APPS
$1.74B
$21.5M 0.86%
+491,443
New +$22.2M
NBIX icon
39
Neurocrine Biosciences
NBIX
$16.6B
$19.4M 0.77%
206,755
+136,782
+195% +$11.6M
MIME
40
DELISTED
Mimecast Limited
MIME
$19.2M 0.76%
241,071
-200,267
-45% -$15.9M
LKQ icon
41
LKQ Corp
LKQ
$6.29B
$19.1M 0.76%
421,656
-14,086
-3% -$720K
STRA icon
42
Strategic Education
STRA
$1.92B
$18.3M 0.73%
276,273
+8,438
+3% +$495K
IOVA icon
43
Iovance Biotherapeutics
IOVA
$2.87B
$18.1M 0.72%
1,085,121
+453,337
+72% +$7.01M
CNTY icon
44
Century Casinos
CNTY
$34M
$17.9M 0.71%
1,496,305
-251
-0% -$2.84K
GDDY icon
45
GoDaddy
GDDY
$11.5B
$17.7M 0.71%
211,463
+69,944
+49% +$5.53M
PGTI
46
DELISTED
PGT, Inc.
PGTI
$16.4M 0.65%
913,998
+470
+0.1% +$9.51K
WIX icon
47
WIX.com
WIX
$2.52B
$16.1M 0.64%
154,527
-2,486
-2% -$271K
WLDN icon
48
Willdan Group
WLDN
$1.3B
$15.9M 0.64%
519,443
+2,175
+0.4% +$67.7K
ASND icon
49
Ascendis Pharma A/S
ASND
$16.8B
$15.8M 0.63%
134,900
+35,039
+35% +$4.06M
AERI
50
DELISTED
Aerie Pharmaceuticals
AERI
$15.3M 0.61%
1,678,609
+475,017
+39% +$3.66M

Similar funds

Rice Hall James & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Rice Hall James & Associates held 327 positions worth $2.51B, down 11% from $2.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q1 2022 filing shows 15 new, 111 increased, 164 reduced and 21 closed positions. Its largest new stake was Digital Turbine: 491,443 shares worth $21.5M. The largest sale was Mimecast Limited, an estimated $15.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Rice Hall James & Associates's largest Q1 2022 buy was Digital Turbine: 491,443 shares worth $21.5M.
  • Rice Hall James & Associates added most to Neurocrine Biosciences in Q1 2022, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q1 2022 reduction was Mimecast Limited, cutting an estimated $15.9M.
  • Rice Hall James & Associates fully exited Zogenix, Inc. in Q1 2022, selling an estimated $12.6M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.51B portfolio in Q1 2022.
  • Rice Hall James & Associates opened 15 new positions and closed 21 in Q1 2022.
  • Rice Hall James & Associates's portfolio value fell 11% quarter-over-quarter to $2.51B.

Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.